Alerts will be sent to your verified email
Verify EmailALKEM
Alkem Laboratories
|
Aurobindo Pharma
|
Abbott India
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
185.0 . | 865.0 . | n/a |
Number of ANDA's Approved By USFDA
|
160.0 . | 733.0 . | n/a |
Number of ANDA's Filed in Europe
|
18.0 | n/a | n/a |
Number of ANDA's Approved in Europe
|
12.0 | n/a | n/a |
Number of ANDA's Filed in Australia
|
42.0 | n/a | n/a |
Number of ANDA's Approved by Australia
|
32.0 | n/a | n/a |
Domestic Sales Growth - YoY
|
73.0 % | n/a | 8.2 % |
R&D as a % of Total Sales
|
3.5 % | 4.7 % | 0.02 % |
Financials
|
|||
5 yr Average ROE
|
17.38 % | 12.72 % | 30.11 % |
5yr average Equity Multiplier
|
1.39 | 1.46 | 1.43 |
5yr Average Asset Turnover Ratio
|
0.86 | 0.68 | 1.14 |
5yr Avg Net Profit Margin
|
14.54 % | 12.5 % | 18.53 % |
Price to Book
|
5.52 | 1.99 | 15.21 |
P/E
|
28.96 | 19.15 | 44.33 |
5yr Avg Cash Conversion Cycle
|
-61.46 Days | -46.37 Days | -46.68 Days |
Inventory Days
|
56.11 Days | 59.62 Days | 45.22 Days |
Days Receivable
|
44.62 Days | 30.33 Days | 19.34 Days |
Days Payable
|
122.42 Days | 121.28 Days | 109.21 Days |
5yr Average Interest Coverage Ratio
|
24.48 | 43.54 | 97.37 |
5yr Avg ROCE
|
22.76 % | 15.27 % | 38.77 % |
5yr Avg Operating Profit Margin
|
18.44 % | 19.22 % | 23.42 % |
5 yr average Debt to Equity
|
0.18 | 0.19 | 0.0 |
5yr CAGR Net Profit
|
6.44 % | -8.16 % | 15.41 % |
5yr Average Return on Assets
|
12.47 % | 8.64 % | 21.03 % |
Shareholdings
|
|||
Promoter Holding
|
53.04 % | 51.82 % | 74.99 % |
Share Pledged by Promoters
|
0.0 | 17.08 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-4.1 % | -0.01 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
8.82 % | 9.14 % | 2.93 % |
Alkem Laboratories
|
Aurobindo Pharma
|
Abbott India
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|